從玉智農(00875.HK)擬折讓約20%發行合共7585.14萬股 淨籌4180萬港元
格隆匯2月21日丨從玉智農(00875.HK)公告,於2025年2月21日,公司與認購人訂立認購協議,據此,公司同意(根據一般授權)發行,而認購人同意認購合共75,851,407股認購股份,每股認購價爲0.560港元。認購價爲每股認購股份0.560港元,較股份於認購協議日期在聯交所所報收市價每股0.700港元折讓約20%;認購事項的所得款項淨額(經扣除公司應付的相關開支)將約爲4180萬港元,每股認購股份的淨價格約爲0.551港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.